Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 6, 2007

Varian Purchases Analogix for $11M to Bolster Lab Consumables Offerings

  • Varian acquired Analogix for approximately $11 million in cash. The transaction also includes future milestone fees over three years that could reach $4 million.

    Varian says that it decided to buy Analogix to strengthen its product portfolio especially in the area of laboratory consumables. Analogix focuses on the development of prepacked columns and instrumentation for automated compound purification using flash chromatography.

    “The acquisition of Analogix is strategic to the advancement of Varian's goal to grow applications-based consumables products and to further broaden its product offering to the pharmaceutical industry,” comments Garry Rogerson, president and CEO, Varian. “Analogix has demonstrated an ability to successfully meet customer needs in the area of drug discovery and to grow its business rapidly in North America. Analogix products will now be distributed more effectively on a global basis via Varian's worldwide distribution network.”



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »